Quality of Recovery From Obstetric Anaesthesia - a Multicentre Study
ObsQoR
1 other identifier
observational
1,638
1 country
1
Brief Summary
Quality of recovery is an important outcome measure in anaesthesia, whilst there are validated tools for this in surgery and regional anesthesia there are no fully validated tools for obstetrics anaesthesia. The aim of this study is to use the Obstetric Quality of Recovery (ObsQoR) score across multiple centres to assess correlation to length of stay and variation for different types of operative and non- operative delivery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 8, 2019
CompletedFirst Posted
Study publicly available on registry
December 10, 2019
CompletedStudy Start
First participant enrolled
October 11, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 24, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
November 24, 2021
CompletedJune 15, 2022
June 1, 2022
13 days
November 8, 2019
June 14, 2022
Conditions
Outcome Measures
Primary Outcomes (2)
• Correlation of ObsQoR with length of hospital stay (LOS) in hours following delivery across multiple centres, particularly ObsQoR score and prediction of prolonged LOS (>1.5 SD) and readmission to hospital.
During the study the total length of stay in hours will be calculated for participating patients. This will be correlated with the score from the ObsQoR survey tool. In addition the readmission status of the patient will be asked at the subsequent survey combined with the patient's health care record to correlate with the ObsQoR tool score. Where the ObsQoR score is measured between 0-100 and LOS will be in hours. Readmission will be a binary outcome measure
Up to 3 months
• The relationship between ObsQoR and patient-reported ready for discharge. This will concurrently be determined to account for institutional, non-medical maternal factors neonatal factors that may delay discharge and impact LOS.
The patient will be surveyed using the ObsQoR tool and also asked regarding when they felt they were ready for discharge to take into account the multitude of factors which may impact on the overall length of stay. Where the ObsQoR score is measured between 0-100 and LOS will be in hours.
up to 3 months
Secondary Outcomes (14)
• Comparing ObsQoR profiles with differing types of obstetric anaesthesia and delivery method.
up to 3 months
• Variations in ObsQoR scores across differing centres.
up to 3 months
• Impact of patient factors on ObsQoR score.
up to 3 months
• Impact of anaesthetic or obstetric factors on ObsQoR score.
up to 3 months
• Impact of neonatal facts on ObsQoR score.
up to 3 months
- +9 more secondary outcomes
Interventions
A survey will be used at 24 hours and 30 days to assess the quality of recovery
Eligibility Criteria
Peripartum women during the designated study period who have received anaesthetic intervention in the previous 24-hour period for 3 consecutive days.
You may qualify if:
- Obstetric patients over 18 years old.
- Intervention occurring after 32/40 gestation.
- All mothers receiving anaesthesia or anaesthetic analgesia during their peripartum period.
You may not qualify if:
- Unable to comprehend the questions asked
- Patient refusal
- Under 32/40 weeks gestation
- Cervical cerclage insertion or removal, anaesthesia for External Cephalic Verison
- Neonatal death
- Non- NHS patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Guy's and St Thomas' NHS Foundation Trustlead
- Stanford Universitycollaborator
Study Sites (1)
Guy's and St Thomas' NHS Foundation Trust
London, SE1 7RT, United Kingdom
Biospecimen
Samples will be taken from selected Caesarean Delivery Patients before and after delivery to analyse to assess immune profiles.
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Kariem El-Boghdadly
GSTT
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 8, 2019
First Posted
December 10, 2019
Study Start
October 11, 2021
Primary Completion
October 24, 2021
Study Completion
November 24, 2021
Last Updated
June 15, 2022
Record last verified: 2022-06
Data Sharing
- IPD Sharing
- Will not share
The raw data will be available on request at the discretion of the central study team